As the first quarter earnings season approaches, Goldman Sachs is advising investors to tread carefully amid rising concerns ...
Goldman Sachs warned sweeping U.S. tariffs will weigh on global growth and prompt the Federal Reserve to cut interest rates ...
The investment banking giant's stock lost 9.3% as of market close and was down as much as 9.5% earlier in the day. The ...
President Vladimir Putin is permitting Goldman Sachs International to sell shares of Russia’s largest energy producers and ...
Goldman Sachs is catching fresh heat over massive bonuses it has pledged to CEO David Solomon and his No. 2 executive John ...
If you're coming in from the wilderness, a creature void of form, these stocks might give you shelter from the storm.
JPMorgan analyst Kian Abouhossein lowered the firm’s price target on Goldman Sachs (GS) to $614 from $625 and keeps an Overweight rating on the ...
Investment bank Goldman Sachs has warned that U.S. President Donald Trump's sweeping new tariffs may spike inflation and ...
Goldman Sachs cut its S&P 500 target and raised its recession forecast. The bank now sees a 35% chance of a recession in the ...
The new forecast sees the Fed lowering rates in July, September and November – an increase from earlier bets on two cuts this ...
(Reuters) - Goldman Sachs raised its 12-month price forecast for Europe's benchmark STOXX 600 stock index, citing the impact ...
Goldman Sachs analyst James Quigley maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of DKK822.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results